DE2743493A1 - Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel - Google Patents

Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Info

Publication number
DE2743493A1
DE2743493A1 DE19772743493 DE2743493A DE2743493A1 DE 2743493 A1 DE2743493 A1 DE 2743493A1 DE 19772743493 DE19772743493 DE 19772743493 DE 2743493 A DE2743493 A DE 2743493A DE 2743493 A1 DE2743493 A1 DE 2743493A1
Authority
DE
Germany
Prior art keywords
acceptable salts
therapeutically acceptable
hydroxyphenoxy
compound
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772743493
Other languages
German (de)
English (en)
Inventor
Enar Ingemar Carlsson
Bo Torsten Lundgren
Gustav Benny Roger Samuelsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of DE2743493A1 publication Critical patent/DE2743493A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Epoxy Compounds (AREA)
DE19772743493 1976-10-07 1977-09-28 Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel Withdrawn DE2743493A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Publications (1)

Publication Number Publication Date
DE2743493A1 true DE2743493A1 (de) 1978-04-13

Family

ID=20329066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772743493 Withdrawn DE2743493A1 (de) 1976-10-07 1977-09-28 Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel

Country Status (22)

Country Link
JP (1) JPS5346928A (fi)
AT (1) AT351509B (fi)
AU (1) AU516727B2 (fi)
BE (1) BE859474A (fi)
CA (1) CA1093096A (fi)
CH (1) CH636337A5 (fi)
CS (5) CS208731B2 (fi)
DD (1) DD132195A5 (fi)
DE (1) DE2743493A1 (fi)
DK (1) DK145375C (fi)
FI (1) FI772936A (fi)
FR (1) FR2367054A1 (fi)
GB (1) GB1589838A (fi)
HU (1) HU177638B (fi)
IE (1) IE45938B1 (fi)
LU (1) LU78263A1 (fi)
NL (1) NL7710941A (fi)
NO (1) NO145436C (fi)
NZ (1) NZ185318A (fi)
SE (1) SE416545B (fi)
SU (3) SU735166A3 (fi)
ZA (1) ZA775603B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPH0627370B2 (ja) * 1985-08-23 1994-04-13 日本エステル株式会社 ポリエステル異形断面太細糸
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590054A (fr) * 1959-04-22 1960-10-24 Pfizer Alkylamines et leur préparation.
GB1264128A (fi) * 1968-06-29 1972-02-16
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
IE45938L (en) 1978-04-07
SE416545B (sv) 1981-01-19
HU177638B (en) 1981-11-28
JPS5346928A (en) 1978-04-27
NO145436C (no) 1982-03-24
CS208730B2 (en) 1981-09-15
DK145375B (da) 1982-11-08
AT351509B (de) 1979-07-25
AU2930077A (en) 1979-04-12
CA1093096A (en) 1981-01-06
CS208732B2 (en) 1981-09-15
SE7611125L (sv) 1978-04-08
SU784760A3 (ru) 1980-11-30
NO145436B (no) 1981-12-14
NO773406L (no) 1978-04-10
CS208731B2 (en) 1981-09-15
DK443177A (da) 1978-04-08
NZ185318A (en) 1980-02-21
AU516727B2 (en) 1981-06-18
FR2367054B1 (fi) 1981-11-06
ATA702177A (de) 1979-01-15
IE45938B1 (en) 1983-01-12
BE859474A (fr) 1978-04-07
CS208733B2 (en) 1981-09-15
FR2367054A1 (fr) 1978-05-05
LU78263A1 (fi) 1978-06-09
FI772936A (fi) 1978-04-08
GB1589838A (en) 1981-05-20
SU735166A3 (ru) 1980-05-15
NL7710941A (nl) 1978-04-11
ZA775603B (en) 1978-06-28
SU959623A3 (ru) 1982-09-15
DK145375C (da) 1983-04-11
CH636337A5 (en) 1983-05-31
DD132195A5 (de) 1978-09-06
CS208734B2 (en) 1981-09-15

Similar Documents

Publication Publication Date Title
EP0400011B1 (de) Neue phenylethanolamine
DE2558501C2 (fi)
DE2502993A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2332837A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0271013B1 (de) Basisch substituierte Phenylacetonitrile, ihre Herstellung und diese enthaltende Arzneimittel
CH372667A (de) Verfahren zur Herstellung von 3-Aryl-3-pyrrolidinolen
DE2531312A1 (de) Aminderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2418030A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD144665A5 (de) Verfahren zur herstellung von 1-phenoxy-3-aminopropan-2-olen
DE2743493A1 (de) Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2530613A1 (de) Aminderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
CH636858A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
DD208799A5 (de) Verfahren zur herstellung von 3-phenoxy-1-carbonylaminoalkyl-aminopropanol-2-en
EP0345591B1 (de) Propanolaminderivate
EP0225543B1 (de) Basisch substituierte Phenylacetaldehyde, ihre Herstellung und diese enthaltende Arzneimittel
DD202692A5 (de) Verfahren zur herstellung neuer derivate des 2-amino-aethanols
EP0013749A1 (de) Hexahydro-1,4-oxazepine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DD213207A5 (de) Verfahren zur herstellung von phenoxy-1-alkylaminopropanolen-2
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
EP0086256B1 (de) 1-(2,4-Dichlorphenoxy)-3-(3,4-dimethoxy-Beta-phenethylamino)-2-propanol, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
DE2460304C2 (de) 1-n-Propyl-4-phthalimido-piperidin-2,6-dion, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
AT345790B (de) Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1- aminopropanen und deren saeureaddtionssalzen
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
WO2001053280A1 (de) Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE2500249A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee